Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants

Myoung Eun Choi,Eun Ji Choi,Jeong Hyeon Lee,Chong Hyun Won,Sung Eun Chang,Mi Woo Lee,Woo Jin Lee
DOI: https://doi.org/10.1093/bjd/ljae224
2024-09-18
Abstract:Background: Amelanotic acral melanoma (AAM) is a rare type of acral melanoma that has a poor prognosis. Objectives: To investigate the transcriptomic differences between AAM and pigmented acral melanoma (PAM). Methods: Differences in the spatially resolved transcriptomic profiles of 9 patients with AAM with 29 regions of interest (ROIs) and 11 patients with PAM with 46 ROIs were investigated using S100b and CD3 morphology markers. Results: In S100b+ tumour cell areas, we detected 11 upregulated differentially expressed genes (DEGs; including chaperone/ubiquitin--associated DEGs) and 82 downregulated DEGs (including human leucocyte antigen) in AAMs vs. PAMs. Protein-protein interaction network and pathway analyses revealed significant enrichment of dysregulated translational and nonsense-mediated decay pathways but significant decreases in antigen processing and presentation, interferon signalling and melanin biosynthesis pathways in S100b+ ROIs of AAMs compared with PAMs. In tumour-associated immune cell areas, the numbers of CD8 T cells (P = 0.04) and M1 macrophages (P = 0.01) were significantly decreased, whereas those of monocytes (P = 0.04) and endothelial cells (P = 0.04) were increased in AAMs compared with PAMs. Conclusions: These findings could widen our understanding of the biological differences between AAMs and PAMs, which might result in a different clinical course.
What problem does this paper attempt to address?